Medicinal cannabis
Cultivation, manufacture, importation and exportation of medicinal cannabis is tightly controlled by the Office of Drug Control (ODC), the Therapeutic Goods Administration (TGA) and local state and territories.
Medicinal cannabis for patients
Medicinal cannabis and products are only available for specific patient groups under medical supervision. Medical practitioners will only be authorised to prescribe medicinal cannabis products for conditions where there is satisfactory scientific evidence supporting such use.
For medicinal cannabis information for consumers and patients the first step is to visit the Therapeutic Goods Administration.
Australian Advisory Council on the Medicinal Use of Cannabis
The AACMC, also known simply as the Council, provides advice to the Assistant Minister for Health and Aged Care on issues relating to the medicinal use of cannabis in accordance with the Therapeutic Goods Act 1989 and the implementation of the regulatory scheme under the Narcotic Drugs Act 1967.
Related information
News
- Medicinal Cannabis Program Regulatory Fees and Charges ReviewThis public consultation is open for comment until 10 February 2023.
- AACMC meeting 19, 9 September 2022The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #19.
- Media release: Medicinal cannabis company Tikun Oceania fined $13,320 for alleged inadequate security and record-keepingThe Office of Drug Control within the Department of Health and Aged Care has issued Queensland-based Tikun Oceana Pty Ltd an infringement notice.
Consultations
- Consultation: Medicinal Cannabis Program Fees and Charges ReviewHave your say on the Medicinal Cannabis Program Fees and Charges Review until 10 February 2023.